PatientsVille.com Logo

PatientsVille

Torvast Side Effects

Common Torvast Side Effects

The most commonly reported Torvast side effects (click to view or check a box to report):

Rhabdomyolysis (9)
Myalgia (8)
Rash (6)
Gamma-glutamyltransferase Increased (6)
Pruritus (5)
Hepatitis Cholestatic (5)
Blood Creatine Phosphokinase Increased (5)
Hypertransaminasaemia (4)
Asthenia (4)
Vomiting (4)
Hepatitis Acute (3)
Abdominal Pain Upper (3)
Blood Alkaline Phosphatase Increased (3)
Jaundice (3)
Weight Decreased (3)
Liver Disorder (3)
Respiratory Failure (3)
Myopathy (3)
Necrosis (2)
Oliguria (2)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Torvast Side Effects Reported to FDA

The following Torvast reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Torvast on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Myalgia
on Dec 13, 2013 Male from IT , 37 years of age, was diagnosed with and was treated with Torvast. Directly after, patient experienced the unwanted or unexpected Torvast side effects: blood creatine phosphokinase increased, blood lactate dehydrogenase increased, myalgia. Torvast dosage: 80 Mg, 1x/day.
Associated medications used:
  • Cardioaspirin (100 Mg, Unk)
  • Efient (10 Mg, Unk)
  • Triatec (1.25 Mg, Unk)
  • Cardicor (2.5 Mg, Unk)
  • Eskim (2000 Mg, Unk)


Pruritus, Blood Creatine Phosphokinase Increased, Rhabdomyolysis
Patient was taking Torvast. Patient felt the following Torvast side effects: pruritus, blood creatine phosphokinase increased, rhabdomyolysis on Jan 06, 2014 from IT Additional patient health information: Male , 39 years of age, was diagnosed with and. Torvast dosage: Unk.
Multiple prescriptions taken:
  • Metformin (500 Mg, 3x/day)
Patient was hospitalized.

Aggression, Agitation, Insomnia
Adverse event was reported on Jan 31, 2014 by a Female taking Torvast (Dosage: 10 Mg, Daily) was diagnosed with and. Location: IT , 91 years of age, After Torvast was administered, patient encountered several Torvast side effects: aggression, agitation, insomnia.
Multiple concurrent drugs taken:
  • Eutirox (50 Ug, Daily)


Hepatic Enzyme Increased, Hepatic Failure, Intracardiac Thrombus
on Jan 21, 2014 Female from IT , 86 years of age, was treated with Torvast. Directly after, patient experienced the unwanted or unexpected Torvast side effects: hepatic enzyme increased, hepatic failure, intracardiac thrombus. Torvast dosage: 40 Mg, Daily.
Associated medications used:
  • Metformin Hcl (3000 Mg, Daily)
  • Plavix (75 Mg, Daily)
  • Levopraid (37.5 Mg, Unk)
  • Fosfomycina Ratiopharm (1 Df, Unk)
Patient was hospitalized.


Rhabdomyolysis, Colitis, Plantar Fasciitis, Tendonitis
on Dec 05, 2013 Male from IT , 72 years of age, was diagnosed with and was treated with Torvast. Patient felt the following Torvast side effects: rhabdomyolysis, colitis, plantar fasciitis, tendonitis. Torvast dosage: 10 Mg, 1x/day.
Multiple prescriptions taken:
  • Acetylsalicylic Acid (100 Mg, Unk)
  • Pantoprazole (1 Df, Unk)
  • Glibomet (3 Df, Unk)
  • Lantus (25 Iu, Unk)
  • Pritorplus (1 Df, Unk)
Patient was hospitalized.

Diabetes Mellitus
Patient was taking Torvast. After Torvast was administered, patient encountered several Torvast side effects: diabetes mellitus on Sep 23, 2013 from IT Additional patient health information: Male , 85 years of age, was diagnosed with and. Torvast dosage: 10 Mg, Daily.
Multiple concurrent drugs taken:
  • Altiazem (180 Mg, Daily)
  • Soldesam (4 Mg, Unk)
  • Keppra (1 Df, Unk)
  • Monocinque (20 Mg, Unk)
  • Clexane (1 Df, Unk)
  • Zestril (20 Mg, Unk)
Patient was hospitalized.

Retinal Haemorrhage
Adverse event was reported on Aug 02, 2013 by a Male taking Torvast (Dosage: 10 Mg, Daily) was diagnosed with and. Location: IT , 50 years of age, Directly after, patient experienced the unwanted or unexpected Torvast side effects: retinal haemorrhage.

Loss Of Consciousness
on Sep 11, 2013 Female from IT , 93 years of age, was treated with Torvast. Patient felt the following Torvast side effects: loss of consciousness. Torvast dosage: 1 Df, Daily.
Multiple prescriptions taken:
  • Cordarone (1 Df, Daily)
  • Coumadin (10 Milligram(s);daily (2 Dose Form Daily))
  • Micardis (1 Df, 1x/day)


Asthenia, Muscle Atrophy, Myalgia
on Aug 05, 2013 Female from IT , 67 years of age, was diagnosed with and was treated with Torvast. After Torvast was administered, patient encountered several Torvast side effects: asthenia, muscle atrophy, myalgia. Torvast dosage: 40 Mg, 1x/day. Patient was hospitalized.

Pancreatitis, Presyncope
Patient was taking Torvast. Directly after, patient experienced the unwanted or unexpected Torvast side effects: pancreatitis, presyncope on Jul 30, 2013 from IT Additional patient health information: Male , 73 years of age, was diagnosed with and. Torvast dosage: 10 Mg, Daily.
Associated medications used:
  • Pantoprazole (20 Mg, Unk)
  • Allopurinol (300 Mg, Unk)
  • Ventolin (Unk)
  • Gaviscon (Unk)
Patient was hospitalized.

Dysuria, Erythema, Pruritus
Adverse event was reported on Jul 31, 2013 by a Male taking Torvast (Dosage: 80 Mg, Daily) . Location: IT , 46 years of age, Patient felt the following Torvast side effects: dysuria, erythema, pruritus.
Multiple prescriptions taken:
  • Effient (10 Mg)
  • Congescor (1.25 Mg)
  • Pantorc (20 Mg)


Myalgia, Abdominal Pain Upper, Paraesthesia
on May 30, 2013 Male from IT , 50 years of age, was diagnosed with and was treated with Torvast. After Torvast was administered, patient encountered several Torvast side effects: myalgia, abdominal pain upper, paraesthesia. Torvast dosage: 80 Mg, 1x/day. Patient was hospitalized.

Anaemia, Myalgia, Rhabdomyolysis, Renal Failure
on Oct 31, 2013 Patient from IT , 84 years of age, weighting 211.6 lb, was diagnosed with and was treated with Torvast. Directly after, patient experienced the unwanted or unexpected Torvast side effects: anaemia, myalgia, rhabdomyolysis, renal failure. Torvast dosage: 40 Mg, Daily.
Associated medications used:
  • Norvasc
  • Antra
  • Cardioaspirin
  • Cefamezin ^pharmacia-upjohn^
  • Lortaan
  • Clexane
  • Zyloric
Patient was hospitalized.

Hypersensitivity
Patient was taking Torvast. Patient felt the following Torvast side effects: hypersensitivity on Oct 22, 2013 from IT Additional patient health information: Male , 75 years of age, was diagnosed with and. Torvast dosage: 80 Mg, 1x/day.
Multiple prescriptions taken:
  • Ranexa (750 Mg, 1x/day)
  • Plavix (Unk)
  • Irbesartan (Unk)
  • Pantoprazole (Unk)


Gamma-glutamyltransferase Increased, Hypertransaminasaemia
Adverse event was reported on May 15, 2013 by a Patient taking Torvast (Dosage: 20 Mg Daily) . Location: IT , 69 years of age, After Torvast was administered, patient encountered several Torvast side effects: gamma-glutamyltransferase increased, hypertransaminasaemia.

Renal Failure, Rhabdomyolysis, Thrombocytopenia, Epistaxis, Hypotension, Hyponatraemia, White Blood Cell Count Decreased, Red Blood Cell Count Decreased
on May 14, 2013 Male from IT , 48 years of age, was diagnosed with and was treated with Torvast. Directly after, patient experienced the unwanted or unexpected Torvast side effects: renal failure, rhabdomyolysis, thrombocytopenia, epistaxis, hypotension, hyponatraemia, white blood cell count decreased, red blood cell count decreased. Torvast dosage: 40 Mg, Daily. Patient was hospitalized.

Hypercreatinaemia, Blood Creatine Phosphokinase Increased
on Apr 19, 2013 Male from IT , 77 years of age, was diagnosed with and was treated with Torvast. Patient felt the following Torvast side effects: hypercreatinaemia, blood creatine phosphokinase increased. Torvast dosage: 10 Mg, Daily.
Multiple prescriptions taken:
  • Dilatrend (Unk)
  • Monoket (Unk)
  • Plavix (Unk)
  • Ascriptin (Unk)
  • Amiodar (Unk)
  • Mirapexin (Unk)
  • Enapren (Unk)
  • Minitran (Unk)
Patient was hospitalized.

Gamma-glutamyltransferase Increased
Patient was taking Torvast. After Torvast was administered, patient encountered several Torvast side effects: gamma-glutamyltransferase increased on Apr 11, 2013 from IT Additional patient health information: Female , 86 years of age, was diagnosed with and. Torvast dosage: 40 Mg, 1x/day.
Multiple concurrent drugs taken:
  • Dilatrend
  • Duoplavin
  • Eutirox
Patient was hospitalized.

Intentional Overdose, Intentional Self-injury, Electrocardiogram Qt Prolonged, Hypotension, Syncope
Adverse event was reported on Apr 17, 2013 by a Female taking Torvast (Dosage: 35 Df, Unit Doses Total) was diagnosed with and. Location: IT , 41 years of age, Directly after, patient experienced the unwanted or unexpected Torvast side effects: intentional overdose, intentional self-injury, electrocardiogram qt prolonged, hypotension, syncope.
Associated medications used:
  • Depakin Chrono (40 Df, Unit Doses Total)
  • Cipralex (70 Df, Unit Doses Total)
Patient was hospitalized.

Hypokalaemia, Myalgia, Rhabdomyolysis, Hypomagnesaemia, Blood Parathyroid Hormone Decreased
on May 09, 2013 Male from IT , 80 years of age, weighting 154.3 lb, was diagnosed with and was treated with Torvast. Patient felt the following Torvast side effects: hypokalaemia, myalgia, rhabdomyolysis, hypomagnesaemia, blood parathyroid hormone decreased. Torvast dosage: 40 Mg, Daily.
Multiple prescriptions taken:
  • Norvasc (10 Mg, Unk)
  • Enapren (5 Mg, Unk)
  • Cardioaspirin (100 Mg, Unk)
  • Amaryl (2 Mg, Unk)
  • Avodart (0.5 Mg, Unk)
  • Xatral (10 Mg, Unk)
  • Omeprazolo Eg (20 Mg, Unk)
Patient was hospitalized.

Hepatotoxicity, Gamma-glutamyltransferase Increased, Transaminases Increased, Blood Alkaline Phosphatase Increased
on Jan 23, 2013 Female from IT , 80 years of age, was diagnosed with and was treated with Torvast. After Torvast was administered, patient encountered several Torvast side effects: hepatotoxicity, gamma-glutamyltransferase increased, transaminases increased, blood alkaline phosphatase increased. Torvast dosage: 40 Mg, Daily.
Multiple concurrent drugs taken:
  • Ticlopidine (Unk)
  • Zarelis (Unk)
  • Folina (Unk)


Myositis
Patient was taking Torvast. Directly after, patient experienced the unwanted or unexpected Torvast side effects: myositis on Dec 04, 2012 from IT Additional patient health information: Male , 41 years of age, weighting 220.5 lb, was diagnosed with and. Torvast dosage: 20 Mg, Daily. Patient was hospitalized.

Eczema, Erythema, Impetigo, Pain, Pruritus
Adverse event was reported on Apr 08, 2013 by a Male taking Torvast (Dosage: Unk) . Location: IT , 85 years of age, Patient felt the following Torvast side effects: eczema, erythema, impetigo, pain, pruritus.
Multiple prescriptions taken:
  • Cumadin (Unk)
  • Zyloric (300 Ug, Daily)
  • Clexane (Unk)
  • Cardioaspirin (Unk)
  • Rocefin (Unk)
Patient was hospitalized.

Gamma-glutamyltransferase Increased, Jaundice, Hypertransaminasaemia
on Feb 25, 2013 Female from IT , 81 years of age, was diagnosed with and was treated with Torvast. After Torvast was administered, patient encountered several Torvast side effects: gamma-glutamyltransferase increased, jaundice, hypertransaminasaemia. Torvast dosage: 20 Mg, 1x/day.
Multiple concurrent drugs taken:
  • Eutirox (50 Ug, Unk)
  • Cardicor (1.25 Mg, Unk)
  • Pritor (80 Mg, Unk)
  • Lanoxin (0.125 Mg, Unk)
Patient was hospitalized.

Hepatitis Acute
on Nov 20, 2012 Female from IT , 78 years of age, was diagnosed with and was treated with Torvast. Directly after, patient experienced the unwanted or unexpected Torvast side effects: hepatitis acute. Torvast dosage: 40 Mg, Daily.
Associated medications used:
  • Metoprolol
  • Combisartan
  • Noradox
  • Zyloric


1 of 4 



Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:

     

    Side Effects

    Scale

    Date & Time

    Other Medicine(s) or Treatment(s)

     

     

     

     

    Scale: 1 = very mild to 10 = very bad


    Track Online

  • User Sign In
  • Register to track your side effects

  • You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.

    Discuss Torvast Side Effects



    Did You Have a Torvast Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Torvast for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Safety Alerts, Active Ingredients, Usage Information

    Alternative TORVAST Names:LIPITOR

    Active Ingredient: ATORVASTA

    More About Torvast

    Side Effects reported to FDA: 80

    Torvast safety alerts: 2012 2010 2003

    Reported deaths: 4

    Reported hospitalizations: 47

    Atorvastatin Calcium Tablets by Ranbaxy Inc.: Recall - Presence of Foreign Substance

    [Posted 11/28/2012]

    AUDIENCE: Pharmacy, Patient, Health Professional

    ISSUE: On November 9, 2012, Ranbaxy Inc. initiated a voluntary recall of 41 affected lots of Atorvastatin Calcium Tablets (10 mg, 20 mg and 40 mg) which is a solid oral dosage form, to the retail level. The Company is taking this voluntary action as a precautionary measure due to the fact that we cannot exclude the possibility that the affected lots may contain very small glass particles resembling a fine grain of sand (less than 1 mm in size). Because of the size of the particles which may be present in the affected lots it is unlikely to cause a significant safety concern. However, the possibility of adverse experiences arising primarily due to physical irritation cannot be ruled out.

    BACKGROUND: The product is used to lower blood cholesterol and is packaged in plastic bottles, as 90 and 500 tablets per bottle. The affected lots of Atorvastatin Calcium Tablets and their respective NDC code, expiration date information can be found in the Firm Press Release. The recall does not affect or relate to the 80 mg dosage strength of Atorvastatin Calcium Tablets.

    RECOMMENDATION:  Consumers should immediately contact their physician or healthcare provider if they have experienced any problems that may be related to taking or using this drug product.

    Healthcare professionals and patients are encouraged to report adverse events or side effects related to the use of these products to the FDA's MedWatch Safety Information and Adverse Event Reporting Program:

    • Complete and submit the report Online: www.fda.gov/MedWatch/report.htm
    • Download form or call 1-800-332-1088 to request a reporting form, then complete and return to the address on the pre-addressed form, or submit by fax to 1-800-FDA-0178.
       

    [11/29/2012 - Questions and Answers - FDA]

    [11/29/2012 - FDA Statement - FDA]

    [11/28/2012 - Firm Press Release - Ranbaxy Inc.]

    Latest Torvast clinical trials